Abstract:Efficient monitoring and assessing the efficacy of vaccines against SARS‐CoV‐2 hinges on swiftly detecting its antibodies. Current methods, often intricate and reliant on nanomaterials, struggle with sensitivity and complexity, limiting their broad use. The immunosensing platform utilized in this work is tailored for quick and precise identification of SARS‐CoV‐2‐specific IgG and Nucleocapsid antibodies. Noteworthy, this platform marks only the second attempt at detecting N‐protein antibodies. Unlike its counterparts, it employs traditional self‐assembled monolayers to foster a selective bond between SARS‐CoV‐2‐specific Nucleocapsid antibodies and a gold electrode coated with the N‐protein antigen. Remarkably, despite eschewing nanomaterials, it matches existing sensors′ sensitivity over a broad detection range (0.025 to 1 ng/mL) with an outstanding limit of detection (0.019 ng/mL). The method's simplicity, reliant solely on immunocomplex reactions, underscores the possibility of achieving effective binding without complex functionalization, rendering it affordable, specific, and highly sensitive. By streamlining the process and eliminating additional steps, this platform presents a practical solution for SARS‐CoV‐2 antibody detection. Its success in N‐protein antibody detection suggests promise for widespread application, especially in resource‐limited settings, for outbreak surveillance and vaccine efficacy evaluation. Rapid and precise detection of SARS‐CoV‐2 antibodies is paramount for effective outbreak monitoring and vaccine efficacy assessment. While existing approaches for antibody detection often rely on complex electrochemical immunosensing with nanomaterial functionalization targeting S‐protein antibodies, their limitations in sensitivity and complexity have hindered widespread application. Here, we present a simplistic immunosensing platform designed for the rapid, and precise detection of SARS‐CoV‐2 specific IgG and Nucleocapsid antibodies. Notably, this study marks only the second exploration of SARS‐CoV‐2 N‐protein antibody detection. The platform utilizes traditional self‐assembled monolayers to establish selective bio‐affinity between SARS‐CoV‐2 specific Nucleocapsid antibodies and a gold electrode functionalized with the N‐protein antigen. Interestingly, despite the absence of nanomaterial functionalization, the developed platform achieves sensitivity comparable to existing sensors across a wide detection range (0.025 to 1 ng/mL) with an impressive limit of detection (0.019 ng/mL). The simplicity of the approach, relying solely on immunocomplex reactions, underscores that effective binding efficiency may be achieved in the absence of complex functionalization and determines its affordability, specificity, and high sensitivity. By eliminating the need for additional functionalization steps, the platform offers a streamlined solution for SARS‐CoV‐2 antibody detection and demonstrates the possibility of N‐protein antibody detection as a promising avenue for widespread application in SARS‐CoV‐2 outbreak monitoring and vaccine efficacy assessment particularly in underdeveloped regions.

Naked-Eye Readable Microarray for Rapid Profiling of Antibodies against Multiple SARS-CoV-2 Variants

SARS-CoV-2 Proteome Microarray for Mapping COVID-19 Antibody Interactions at Amino Acid Resolution

N protein-based ultrasensitive SARS-CoV-2 antibody detection in seconds via 3D nanoprinted, microarchitected array electrodes

Development of a double‐antibody sandwich ELISA for detection of SARS‐CoV‐2 variants based on nucleocapsid protein‐specific antibodies

Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection

Nanoparticle-Supported, Rapid, and Electronic Detection of SARS-CoV-2 Antibodies and Antigens at Attomolar Level

Multiplex quantitative detection of SARS-CoV-2 specific IgG and IgM antibodies based on DNA-assisted nanopore sensing

Novel enzyme-linked aptamer-antibody sandwich assay and hybrid lateral flow strip for SARS-CoV-2 detection

Plasmonically Enhanced Ultrasensitive Epitope-Specific Serologic Assay for COVID-19

Multiplexed discrimination of SARS-CoV-2 variants via plasmonic-enhanced fluorescence in a portable and automated device

Multiplexed Lab-on-a-Chip Bioassays for Testing Antibodies against SARS-CoV-2 and Its Variants in Multiple Individuals

A high-throughput microfluidic nanoimmunoassay for detecting anti–SARS-CoV-2 antibodies in serum or ultralow-volume blood samples

Microfluidic Immunoassays for Sensitive and Simultaneous Detection of IgG/IgM/Antigen of SARS-CoV-2 within 15 min

Development of Detection Antibody Targeting the Linear Epitope in SARS-CoV-2 Nucleocapsid Protein with Ultra-High Sensitivity

Platinum-Decorated Gold Nanoparticle-Based Microfluidic Chip Immunoassay for Ultrasensitive Colorimetric Detection of SARS-CoV-2 Nucleocapsid Protein

Rapid and sensitive detection of SARS-CoV-2 based on a phage-displayed scFv antibody fusion with alkaline phosphatase and NanoLuc luciferase

Rapid Detection of SARS-CoV-2 Nucleocapsid Protein by a Label-free biosensor based on Optical Fiber Cylindrical Micro-resonator

High-affinity aptamers enable the rapid optical detection and differentiation of three SARS-CoV-2 VOCs

A Multiplexed SERS Microassay for Accurate Detection of SARS-CoV-2 and Variants of Concern

Rapid and Sensitive Detection of anti-SARS-CoV-2 IgG, Using Lanthanide-Doped Nanoparticles-Based Lateral Flow Immunoassay

A Simplistic Label‐Free Electrochemical Immunosensing Approach for Rapid and Sensitive Detection of Anti‐SARS‐COV‐2 Nucleocapsid Antibodies